Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Legend

Leesa Legend Hybrid Mattress review 2025

The Leesa Legend Hybrid Mattress provides top tier pressure relief for side sleepers. But is it worth the money? Here's what we think after sleeping on it for a month.

Tom’s Guide

Decentralized finance platform Legend raises $15 million from a16z and Coinbase

Former Compound CEO is launching a DeFi platform to help investors trade, borrow, and earn crypto.

Fortune

Arcellx And Legend Bio Trade Jabs In Multiple Myeloma. But Only One Pulls Ahead.

Arcellx stock reversed lower Monday on positive results for its rival to Legend Biotech's multiple myeloma treatment, Carvykti.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

'I'm more than able': Glastonbury Legends slot to be headlined by Rod Stewart

SIR Rod Stewart will play the Glastonbury Legends slot in 2025, it has been announced...

The National (Scotland)

Treasure Island - We Discover One Of Planet Golf’s Finest Holiday Destinations

The outstandingly beautiful island of Mauritius is home to some equally scenic golf

Golf Monthly

Defiant Highland spirit makes this constituency hard to predict

LEGEND has it the two guns on display at the Glenlivet distillery were given to George Smith, the first operator of a legal distillery in the…

The National (Scotland)

Jason Becker hailed his “stunning technique and explosive guitar tone” – now Jien Takahashi is building a unique brand of shred shaped by Ritchie Blackmore, Morbid Angel and a quest to prove “a guitar solo can be as persuasive as a singer's voice”

The rising Japanese virtuoso has an undying love for the shred heroics of Becker and Marty Friedman, but also uses his Ibanez, PRS and occasionally his $50 Legend Strat copy to traverse much wider melodic ground

Guitar World

Read news from The Economist, FT, and more,
with one subscription

Arcellx, A Top 5% Biotech, Dives After A 'Perfect Storm' Leads To A Patient's Death

The FDA placed a study of Arcellx's multiple myeloma drug on hold after a patient died, leading ACLX stock to crumble Tuesday.

Investors Business Daily

Remembering 'Legends': The underground nightclub 'second only to Hacienda'

For many clubbers, Thursday nights are when the weekend really begins

Manchester Evening News

Legend Bio Hits Profit-Taking Zone After Confirming Leaked Test Results

Legend confirmed the leaked results of its multiple myeloma study on Friday, leading LEGN stock to surge to a profit-taking range.

Investors Business Daily

Legend Breaks Out After Leaked Documents Show Promise In $9.6 Billion Market

Legend Biotech is staring down a $9.6 billion opportunity, an analyst said Wednesday as LEGN stock soared on positive cancer test results.

Investors Business Daily

Auto review: An overdue return of an old friend: the 2023 Acura Integra

In Romeo and Juliet, William Shakespeare argued, “What's in a name? That which we call a rose by any other name would smell just as sweet.”

Tribune News Service

Sobè Decor’s Deepavali launches for 2022

Black porcelain canisters, dinner sets with miniature florals, and Latvian knives. The festive collection at Sobè Decor features an interesting mix of tableware and accessories

The Hindu

French Motorcycle Maker Archive Launches The Legend Retro Helmet

French motorcycle manufacturer Archive releases The Legend full-face helmet with an ECE 22.05 approval rating and a Bell Bullitt-inspired design.

RideApart

Get all your
news in one place.

100’s of premium titles.
One news app.

Bangkok Post

Legends on the wrist

After his parents took him to a watch restorer's workshop, teenage Christophe Claret became fascinated with complicated timepieces, and particularly attracted to minute repeaters that strike hours, quarters and minutes on demand.

Benzinga

Legend Biotech Shares Move Higher After Bullish BMO Pitch

BMO Capital Markets initiated coverage on Legend Biotech Corporation (NASDAQ:LEGN) with a price target of $77, and an Outperform rating. The analyst says the company's recently approved Carvykti for multiple myeloma is best-in-class late-line CAR T therapy. Related: EMA's CHMP Clears Janssen, Legend's Multiple Myeloma CAR-T Therapy Though the analyst expects a gradual increase in sales due…

The Hindu

Volkswagen announces Legend edition price

Volkswagen has priced its Legend edition at ₹ 10.25 lakh, with the special edition based on the GT

Benzinga

FDA Approves JNJ-Legend Biotech Partnered Blood Cancer Therapy

The

Get all your
news in one place.

100’s of premium titles.
One news app.

Manchester Evening News

Fifth Avenue nights of carnage - from £1 ‘quad vods’ to Chuckle Brothers ‘pandemonium’ and a mechanical bull

The iconic Manchester nightclub has closed it's doors for the final time

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.